StockCall.com Provides Stock Research on Sequenom Inc., Peregrine Pharmaceuticals Inc., Optimer Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., and Inovio Pharmaceuticals Inc.
New York City, New York -- (May 16, 2013)
U.S. spending on medicines slipped in 2012, according to a recent report by IMS. The data highlights the fact that the “patent cliff”, which refers to the expiration of patents on several blockbuster drugs, is having a major impact on drug makers. The key for drug makers will be to boost their product pipelines. One of the ways major drug manufacturers can boost their product pipeline is through collaboration with innovative biotechnology companies that have developed or are developing potential blockbuster drugs. On Wednesday, biotechnology stocks ended on a mixed note even as the broad closed at record high levels. Among the major movers in the sector were Sequenom Inc. (NASDAQ: SQNM), Peregrine Pharmaceuticals (NASDAQ: PPHM), Optimer Pharmaceuticals Inc. (NASDAQ: OPTR), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) and Inovio Pharmaceuticals Inc. (NYSE: INO). StockCall has issued technical analysis and charting reports on SQNM, PPHM, OPTR, ONXX, and INO. Download these free reports now at
Sequenom Inc. traded in the range of $4.23 and $4.40 in its latest trading session and ended it at $4.24, down 0.12 percent. The stock’s 52 weeks range stands at $2.65 and $5.36. Sequenom has lost 18.05 percent of its value in the past 12 months while it lost 5.67 percent on a YTD basis. The stock is in a neutral mode and may find its first support level at $4.10. On the upside, it may touch $4.55 in the coming trading sessions. It is trading above its 20-day moving average of $3.78. Download the free research on SQNM today by registering at
Peregrine Pharmaceuticals stock enhanced its YTD returns with 2.70 percent gain in Wednesday’s trading session. The stock traded in the range of $1.51 and $1.61 and closed at $1.56. However, it traded higher-than-average number of shares at 2.96 million. The stock is in a neutral mode and is likely to maintain its upward ascent in the coming sessions. Its first resistance level is at $1.62 and it may test the support level of $1.44 in the coming trading sessions. The company commands market capitalization of $213.89 million. Sign up and have access to our free report on PPHM at
In-line with the uptrend shown by broad market indices, Optimer Pharmaceuticals Inc.’s stock finished 13.54 percent higher at $16.18, with volume up from daily average of 931,693 to 5.33 million. The stock is up so far in 2013 with its year-to-date gain at 82.21 percent. However, the stock currently shows a bullish trend which is further confirmed by its MACD chart. Optimer has its first support level at $15.49. Sign up and read the complimentary report on OPTR at
Onyx Pharmaceuticals Inc. closed Wednesday’s trading session at $98.74, down 1.62 percent from its previous close. The stock shows a bullish trend but currently is in overbought territory with Relative Strength Index of 60.68. It is likely to face mild pullback in the coming trading sessions and may find support at $97.30. Upon breaching this level, it may go down to $94.54 level. Onyx traded 942,150 shares during yesterday’s session, and the stock oscillated in the range of $97.82 and $101.43. ONXX has appreciated 123.04 percent in the past 52 weeks. The free report on ONXX can be downloaded by signing up now at
Inovio Pharmaceuticals Inc. made a mild upward movement with 0.03 percent gain in its latest trading session. The company’s stock ended at $0.66 and its highest price point for the session stood at $0.68. In the past 12 months, the stock has gained 32 percent while its YTD gain stands at 36.03 percent. Inovio trades at beta of 2.79 which implies high volatility. It traded 1.63 million shares during the session in comparison to its regular daily volume of 1.46 million shares. Free report on INO can be accessed by registering at
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
William T. Knight
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here